Secondly, SLC6A19 plays a significant role in ccRCC and presents intimately correlation with fatty acid metabolism alongside with CPT1A, which is extensively considered as a tumor suppressor of ccRCC. The gene discussed is CPT1A; the disease is nonpapillary renal cell carcinoma.